AwardsandRecognitions-PioneeringPrecisionOncology

GoogleAnalyticssnippetaddedbySiteKit

EndGoogleAnalyticssnippetaddedbySiteKit

GoogleTagManagersnippetaddedbySite Kit 

 End Google Tag Manager snippet added by Site Kit 

 Google Tag Manager (noscript) snippet added by Site Kit 

 End Google Tag Manager (noscript) snippet added by Site Kit 

Solid Biopsy (OncoDEEP® Kit)Liquid Biopsy (OncoSELECT® Kit)Molecular Residual Disease (MRD)OncoCDI – Clinical Data Intelligence 

Clinical TestingPrecision enrollmentMRD for PharmaKnowledge-driven medicineClinical Data Intelligence (OncoCDI®) 

Solid Biopsy (OncoDEEP®)Liquid Biopsy (OncoSELECT®)Cancer Monitoring (OncoFOLLOW®)Molecular Residual Disease (MRD) 

About UsCertifications & AccreditationsTeamAwardsCareersIntegraGen subsidiary investors

	Since our early days in 2012, we have established a proven track record in precision oncology. Local and international institutions have recognised our continuous growth, empowering our team to redouble efforts to make precision medicine in oncology a reality. Whatever the challenges, we will continue to set the bar high and to disrupt technology in personalised cancer therapy.

Winner of Deloitte’s 2020 Technology Fast 50

Deloitte Belgium granted us for the second time the award of the fastest growing tech company headquartered and founded in Belgium in the biotech and pharma category. “Winning the award multiple times is very rare, as each year the challenge to grow our turnover is more and more difficult”, said Jean-Pol Detiffe, Founder of OncoDNA. 

Winner of Deloitte’s 2018 Technology Fast 50

We won Deloitte Belgium’s Fast 50 Technology Competition in the healthcare and life sciences category for the first time in 2018. The award recognised OncoDNA as the fastest growing tech company in the field in terms of percentage of growth in turnover over the past four years. 

Winner of the AWEX’s Tremplin Export Prize

The Wallonia Export-Investment Agency (AWEX) awarded us the Tremplin Prize “Grande Exportation”. The prize recognised our successful export performance, following our global expansion into over 60 countries most notably beyond Europe. Mr. Paul Magnette, former Wallonia’s Minister-President, was present at the award ceremony. 

Interview with Jean-Pol Detiffe

Winner of Deloitte’s Most Disruptive Innovator Award

OncoDNA was named “Most Disruptive Innovator” in the rising star category of Deloitte Belgium’s Fast 50 Technology Competition in 2015. The award recognises fast growing companies that have developed a product or services that make very high-end technology accessible for wide application and use. 

Winner of EY Entrepreneur of the Year Award

Ernst & Young celebrated our entrepreneurial achievement by electing us as the Most Promising only three years after our foundation in 2012. The global program supports companies that demonstrate vision, leadership and success. 

OncoDNA is a theranostic and genomic company with renown expertise in precision oncology and genetic diseases. 

Company 

OncoDNA S.A. (headquarters)Rue Louis Breguet 1BE-6041 Gosselies

+32 (0) 71 18 35 00 

	©OncoDNA 2024. All rights reserved. VAT:BE0501631837	

	Made by Créatonit   Sitemap 

 Consent Management powered by Complianz | GDPR/CCPA Cookie Consent https://wordpress.org/plugins/complianz-gdpr 

To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.

The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.

The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.

The technical storage or access that is used exclusively for statistical purposes.
The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.

The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.

Manage {vendor_count} vendors
Read more about these purposes

Manage consent
 Start of Async HubSpot Analytics Code 

 End of Async HubSpot Analytics Code 

 This website is like a Rocket, isn't it? Performance optimized by WP Rocket. Learn more: https://wp-rocket.me - Debug: cached@1712129202